Researchers call on regulators to reduce risks of AI in medicine
Continuous monitoring is critical if regulatory agencies such as the Food and Drug Administration are to reduce the risk in artificial and machine learning-based medical technology.
More for you
See AllLoading data for hdm_tax_topic #better-outcomes...